O'HEERON PETE 4
4 · FibroBiologics, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
O'HEERON PETE
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common Stock
[F1]2026-03-02$0.35/sh+17,428$6,152→ 5,924,075 total - Purchase
Common Stock
[F1]2026-03-03$0.41/sh+18,200$7,373→ 5,942,275 total - Purchase
Common Stock
[F1]2026-03-04$0.38/sh+15,872$6,006→ 5,958,147 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3210 to $0.4166 on March 2, 2026, $0.3885 to $0.4302 on March 3, 2026, and $0.3730 to $0.3820 on March 4, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Signature
/s/ Ruben A. Garcia, by Power of Attorney|2026-03-04